Relevant Features in Nonalcoholic Steatohepatitis Determined Using Machine Learning for Feature Selection

被引:18
作者
Garcia-Carretero, Rafael [1 ]
Vigil-Medina, Luis [1 ]
Barquero-Perez, Oscar [2 ]
Ramos-Lopez, Javier [2 ]
机构
[1] Rey Juan Carlos Univ, Mostoles Univ Hosp, Dept Internal Med, Mostoles, Spain
[2] Rey Juan Carlos Univ, Dept Signal Theory & Commun & Telemat Syst & Comp, Fuenlabrada, Spain
关键词
nonalcoholic steatohepatitis; metabolic syndrome; machine learning; FATTY LIVER-DISEASE; METABOLIC SYNDROME; INSULIN-RESISTANCE; VARIABLE SELECTION; PREDICTIVE-VALUE; SERUM FERRITIN; ALT LEVELS; ASSOCIATION; RISK; REGULARIZATION;
D O I
10.1089/met.2019.0052
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: We investigated the prevalence and the most relevant features of nonalcoholic steatohepatitis (NASH), a stage of nonalcoholic fatty liver disease, (NAFLD) in which the inflammation of hepatocytes can lead to increased cardiovascular risk, liver fibrosis, cirrhosis, and the need for liver transplant. Methods: We analyzed data from 2239 hypertensive patients using descriptive statistics and supervised machine learning algorithms, including the least absolute shrinkage and selection operator and random forest classifier, to select the most relevant features of NASH. Results: The prevalence of NASH among our hypertensive patients was 11.3%. In univariate analyses, it was associated with metabolic syndrome, type 2 diabetes, insulin resistance, and dyslipidemia. Ferritin and serum insulin were the most relevant features in the final model, with a sensitivity of 70%, specificity of 79%, and area under the curve of 0.79. Conclusion: Ferritin and insulin are significant predictors of NASH. Clinicians may use these to better assess cardiovascular risk and provide better management to hypertensive patients with NASH. Machine-learning algorithms may help health care providers make decisions.
引用
收藏
页码:444 / 451
页数:8
相关论文
共 42 条
  • [1] Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
    Adams, Leon A.
    Harmsen, Scott
    St Sauver, Jennifer L.
    Charatcharoenwitthaya, Phunchai
    Enders, Felicity B.
    Therneau, Terry
    Angulo, Paul
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (07) : 1567 - 1573
  • [2] Alam Shahinul, 2016, World J Gastrointest Pathophysiol, V7, P211, DOI 10.4291/wjgp.v7.i2.211
  • [4] [Anonymous], 2017, R LANG ENV STAT COMP
  • [5] [Anonymous], MACH LEARN MACH LEARN
  • [6] Feature selection in machine learning: A new perspective
    Cai, Jie
    Luo, Jiawei
    Wang, Shulin
    Yang, Sheng
    [J]. NEUROCOMPUTING, 2018, 300 : 70 - 79
  • [7] Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
    Castera, Laurent
    [J]. SEMINARS IN LIVER DISEASE, 2015, 35 (03) : 291 - 303
  • [8] The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Charlton, Michael
    Cusi, Kenneth
    Rinella, Mary
    Harrison, Stephen A.
    Brunt, Elizabeth M.
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 328 - 357
  • [9] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [10] Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis
    DeFilippis, Andrew Paul
    Blaha, Michael J.
    Martin, Seth S.
    Reed, Robert M.
    Jones, Steven R.
    Nasir, Khurram
    Blumenthal, Roger S.
    Budoff, Matthew J.
    [J]. ATHEROSCLEROSIS, 2013, 227 (02) : 429 - 436